Literature DB >> 17882922

Rhinosinusitis Task Force symptoms versus the Sinonasal Outcomes Test in patients evaluated for chronic rhinosinusitis.

Francis T K Ling1, Stilianos E Kountakis.   

Abstract

BACKGROUND: The aim of this study was to compare Rhinosinusitis Task Force (RSTF) symptom scores with Sinonasal Outcome Test 20 (SNOT-20) in patients with chronic rhinosinusitis (CRS) and controls.
METHODS: An analysis was performed of prospectively collected data in patients with CRS (n=201) and controls (n=100). The severity of individual RSTF major and minor symptom scores graded on a visual analog scale and total symptom scores were compared between the two groups. Correlation of the RSTF symptoms with the SNOT-20 was performed using data collected from the CRS group at baseline and at 1 year postoperatively.
RESULTS: CRS patients had higher RSTF symptom scores compared with control patients when asked to rate the severity of nasal obstruction, facial pain/pressure, facial congestion, alteration of smell, nasal discharge, postnasal drip, headache, halitosis, fatigue, cough, and ear pain (p < 0.005). No statistically significant difference was seen for the symptoms of dental pain and fever. Total RSTF scores were 54.5 +/- 1.9 in CRS patients versus 23.4 +/- 3.0 in controls. Total SNOT-20 scores were 28.7 +/- 0.8 in CRS patients versus 15.2 +/- 0.6 in controls. In CRS patients, total RSTF scores correlated with total SNOT-20 scores at baseline (r = 0.36; p < 0.0001) and 1-year postoperatively (r = 0.37; p < 0.0001).
CONCLUSION: Total RSTF symptom scores are significantly different in patients with chronic rhinosinusitis compared with those without this disease. The total RSTF symptom scores also correlate with a validated outcome measures instrument.

Entities:  

Mesh:

Year:  2007        PMID: 17882922     DOI: 10.2500/ajr.2007.21.3052

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  3 in total

1.  Correlation of intensity-modulated radiation therapy at a specific radiation dose with the prognosis of nasal mucous damage after radiotherapy.

Authors:  Gendi Yin; Bo Tu; Ling Ye
Journal:  Radiat Environ Biophys       Date:  2020-02-06       Impact factor: 1.925

Review 2.  Comparison of disease-specific quality-of-life instruments in the assessment of chronic rhinosinusitis.

Authors:  Lourdes Quintanilla-Dieck; Jamie R Litvack; Jess C Mace; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2012-06-13       Impact factor: 3.858

Review 3.  Assessing nasal symptom control.

Authors:  Nkiruka U Erekosima; Rohit K Katial
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.